Quarterly report pursuant to Section 13 or 15(d)

Convertible Debt - Related Party (Detail Textuals 1)

v3.19.1
Convertible Debt - Related Party (Detail Textuals 1)
1 Months Ended 3 Months Ended
Jan. 19, 2018
$ / shares
shares
Dec. 28, 2017
USD ($)
Day
$ / shares
Mar. 31, 2018
USD ($)
Mar. 31, 2019
USD ($)
Short-term Debt [Line Items]        
Proceeds from secured convertible promissory note - related party     $ 400,000  
Convertible debt       $ 2,914,237
Loss on extinguishment of debt     $ (590,392)  
Emerald Health Sciences Inc        
Short-term Debt [Line Items]        
Initial conversion price | $ / shares $ 0.10      
Number of notes converted into common stock | shares 9,000,000      
Effective interest rate     13.94%  
Multi-Draw Credit Agreement        
Short-term Debt [Line Items]        
Effective interest rate       9.89%
Bridge Loan | Secured promissory note and security agreement | Emerald Health Sciences Inc        
Short-term Debt [Line Items]        
Aggregate gross proceeds   $ 900,000    
Bridge loan interest rate   12.00%    
Initial conversion price | $ / shares   $ 0.10    
Proceeds from secured convertible promissory note - related party   $ 500,000    
Funding of remaining bridge loan   400,000    
Convertible debt   $ 265,000    
Number of trading days as of financing close date | Day   1    
Additional conversion liability   $ 360,000